Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Review Article

Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs

Author(s): Ghansham S. More*, Asha B. Thomas, Sohan S. Chitlange, Rabindra K. Nanda and Rahul L. Gajbhiye

Volume 19, Issue 9, 2019

Page: [1080 - 1102] Pages: 23

DOI: 10.2174/1871520619666190305141458

Price: $65

Abstract

Background & Objective: Nitrogen mustard derivatives form one of the major classes of anti-cancer agents in USFDA approved drugs list. These are polyfunctional alkylating agents which are distinguished by a unique mechanism of adduct formation with DNA involving cross-linking between guanine N-7 of one strand of DNA with the other. The generated cross-linking is irreversible and leads to cell apoptosis. Hence it is of great interest to explore this class of anticancer alkylating agents.

Methods: An exhaustive list of reviews, research articles, patents, books, patient information leaflets, and orange book is presented and the contents related to nitrogen mustard anti-cancer agents have been reviewed. Attempts are made to present synthesis schemes in a simplified manner. The mechanism of action of the drugs and their side effects are also systematically elaborated.

Results: This review provides a platform for understanding all aspects of such drugs right from synthesis to their mechanism of action and side effects, and lists USFDA approved ANDA players among alkylating anticancer agents in the current market.

Conclusion: Perusing this article, generic scientists will be able to access literature information in this domain easily to gain insight into the nitrogen mustard alkylating agents for further ANDA development. It will help the scientific and research community to continue their pursuit for the design of newer and novel heterocyclic alkylating agents of this class in the coming future.

Keywords: Alkylating agents, nitrogen mustard compounds, cross-linking reagents, bendamustine hydrochloride, USFDA, anti-cancer agents.

Graphical Abstract

[1]
Wheeler, G.P. Studies related to the mechanism of action of cytotoxic alkylating agents: A review. Cancer Res., 1962, 22(6), 651-688.
[2]
Edward, C.; Edelson, R. Yale cancer center: Past, present, and future. Yale J. Biol. Med., 2006, 79(3-4), 199-200.
[3]
Weber, G.F. DNA-damaging drugs, WeberEd. Springer International Publishing Switzerland, 2015, Vol. 2,, 2-18.
[4]
Scholar, E. Alkylating agents. Biomed. Sci., 2007, 1-4.
[5]
Gilman, A. The initial clinical trial of nitrogen mustard. Am. J. Surg., 1963, 105(5), 574-578.
[6]
Kater, A.P. Efficacy and safety of first-line therapy with Chlorambucil, Rituximab, and Lenalidomide (Revlimid®) (CR2) in elderly patients and youngfrail patients with advanced Chronic Lymphocytic Leukemia (CLL): A phase I/II trial. Hoven109 CLL, 2014, 6, 1-79.
[7]
Francesco, P.; Fermo, S.L. Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis. Autoimmune Dis., 2011.961702
[8]
Brayfield, A. Cyclophosphamide: Martindale: The Complete Drug Reference, Medicines Complete Ed.;UK Pharmaceutical Press: London, 2017.
[9]
Devrieze, B.W.; Hurley, J.A. Goodpasture Syndrome (Antiglomerular Basement Membrane Antibody Disease); Ed. Statpearls Publishing LLC: Treasure Island, USA . , 2018.
[10]
Facon, T.; Mary, J.Y.; Hulin, C. Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): A randomised trial. Lancet, 2007, 370(9594), 1209-1218.
[11]
Zalupski, M.; Baker, L.H. Ifosfamide. J. Natl. Cancer Inst., 1988, 80(8), 556-566.
[12]
Plosker, G.L.; Carter, N.J. Bendamustine: A review of its use in the management of indolent Non-Hodgkin lymphoma. Drugs, 2008, 68(18), 2645-2660.
[13]
Cancer statistics, 2018. CA Cancer J. Clin., 2018, 68(1), 7-30.
[15]
Vardanyan, R.; Hruby, V. Antineoplastics, Victor J. Hruby Ed.. Elsevier: Amsterdam,, 2006; pp. 389-418.
[16]
Sriram, D.; Yogeeswari., P. Anticancer Agents; Thomas Mathew, Ed. Pearson Education V: India,. , 2010, pp. 557-584.
[17]
National Library of Medicine. Medline Plus. Drugs, herbs, and supplements: Mechlorethamine.. medlineplus.gov/druginfo/meds/a682223.html (Accessed Aug 25,2018).
[18]
Bunn, P.A.; Hoffman, S.J.; Norris, D.; Golitz, L.E.; Aeling, J.L. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome). Ann. Intern. Med., 1994, 121(8), 592-602.
[19]
Huazhong, J.Q.S.L. A synthetic process of antineoplastic agents chlorambucil butyrate. Chinese Patent CN104447376B, , Nov 05 . 2014.
[20]
Walter, C.J.R.; Everett, J.L.; Roberts, J.J.N. N-Dichloroethylaminobutyrates and preparation thereof. U.S. Patent 2944079 , July 05. 1960.
[21]
Phillips, A.P. Tuckahoe; Mentha, J.W.; Hartsdale.; Method of making Chlorambucil. U. Patent 3046301,, July 24 . 1962.
[22]
National Cancer Institute. About Cancer., Cancer Treatment Chlorambucil.Cancer.gov/about-cancer/treatment/drugs/chlorambucil (Accessed Aug 25, 2018).
[23]
Nedaa, I.; Sonnenburga, R.; Schmutzler, R.; Niemeyerb, U.; Kutscher, B.; Engel, J.; Kleemann, A. A new method for the preparation of ifosfamide and cyclophosphamide. J. Nat. Res., 1997, 52, 943-946.
[24]
Anon., Drugs of choice for cancer. Med. Lett., 2003, 1, 41-52.
[25]
National Cancer Institute. About cancer. Cancer treatment cyclophosphamide. cancer.gov/about-cancer/treatment/drugs/cyclophosphamide (Accessed Aug 25, 2018).
[26]
Gurjar, M.K.; Tripathy, N.K.; Kotharkar, S.A.; Patil, P.N.; Mehta, S.S. Process for the preparation of melphalan hydrochloride. U.S. Patent 0116117 A1, May 10, . 2012.
[27]
Ashnagar, A.; Gharib Naseri, N.; Darakhshanmehr, M. Synthesis and elucidation of 4-bis(2-Chloroethyl)-amino-L-phenylalanine. Asian J. Chem., 2007, 19(7), 5399-5406.
[28]
Niemeyer, U.; Niege, H.; Kutscher, B.; Neda, I. Process for the preparation of Oxaphosphorine-2-amines. U.S. Patent 0047103 A1, Nov 29. 2001.
[29]
Pankiewicz, K.; Kinas, R.; Stec, W.J.; Foster, A.B.; Jarman, M.; Van Maanen, J.M.S. Synthesis and absolute configuration assignments of enantiomeric forms of ifosphamide, sulfosphamide, and trofosphamide. J. Am. Chem. Soc., 1979, 101(26), 7712-7718.
[30]
Schickaneder, H. Eckental.; Schickaneder, C.; Lauf, A.D.; Pegnitz; Limmert, M. Dresden.; Process for the preparation of bendamustine hydrochloride and related compounds. U.S. Patent 2013/0184471 A1, Jul 18. 2013.
[31]
Mishra, B.B.; Shambhubha, N.; Kachhadia, ; Tomar, V.S.; Lahiri, S. Process for the preparation of bendamustine hydrochloride. U.S. Patent 2014/0121383 A1, May 1 . 2014.
[32]
Ozegowski, W.; Krebs, D. Aminosäureantagonisten. III. ω-[Bis-(β-chloräthyl)-amino-benzimidazolyl-(2)]-propion- bzw.-buttersäurenalspotentielle Cytostatika. J. Prakt. Chem., 1963, 20, 178-186.
[33]
Madkou, L.H. Biotechnology of nucleic acids medicines as gene therapeutics and their drug complexes. Chron. Pharma Sci, 2017, 1(4), 204-253.
[34]
Trituration of Mustargen, Merck & Co., Whitehouse Station, NJ 08889, USA, 741793X..
[35]
Bruce, A. Chabner, Bertino, J.; Cleary, J.; Ortiz, T.; Lane, A.; Supko, J.G.; Ryan, D. Cytotoxic compounds; Alkylating Agents and Platinum co-ordination complexes; Goodman & Gilman’s The Pharmacological Basis of Therapeutics; Ed. The McGraw-Hill Companies, Inc., 2011, pp. 1677-1678.
[36]
Beglleiter, A.; Mowat, M.; Israels, L.G.; Johnston, J.B. Chlorambucil in chronic lymphocytic leukemia: Mechanism of action. Leuk. Lymphoma, 1996, 23(3-4), 187-201.
[37]
Accessdata FDA, LEUKERAN Chlorambucil Tablet Prescribing Information, Reference ID 3036543, GlaxoSmithKline, Research Triangle Park, NC 27709..
[38]
Chighizola, C.; Ong, V.H.; Denton, C.P. Cyclophosphamide as disease-modifying therapy for scleroderma. Int. J. Clin. Rheumatol., 2011, 6(2), 219-230.
[39]
Tilby, M.J.; Hall, A.G. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev., 1992, 6(3), 163-173.
[40]
Emadi, A.; Jones, R.J.; Brodsky, R.A. Cyclophosphamide and cancer: Golden anniversary. Nat. Rev. Clin. Oncol., 2009, 6, 638-647.
[41]
Osborne, M.R.; Lawley, P.D.; Crofton-sleigh, C.; Warren, W. Products from alkylation of DNA in cells by melphalan: Human soft tissue sarcoma cell line RD and Escherichia coli WP2. Chem. Biol. Interact., 1995, 97(3), 287-296.
[42]
Povirk, L.F.; Shuker, D.E. DNA damage and mutagenesis induced by nitrogen mustards. Mutat. Res., 1994, 318(3), 205-226.
[43]
Highlights of prescribing information, EVOMELA; 2016.Reference ID 3900023, Spectrum Pharmace.uticals, Ins., Irvine, CA 92618.
[44]
Furlanut, M.; Franceschi, L. Pharmacology of ifosfamide. Oncology, 2003, 65(2), 2-6.
[45]
Ifosfamide, injection solution; Highlights of prescribing Information,; 2015.Teva Pharmaceuticals USA, Inc., North Wales, PA 19454..
[46]
Struck, R.F.; Dykes, D.J.; Corbett, T.H.; Suling, W.J.; Trader, M.W. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumors comparable to Cyclophosphamide. Br. J. Cancer., 1983, 47, 015-026.
[47]
Accessdata, F.D.A. TREANDA Bendamustine hydrochloride for injection, for intravenous infusion, Highlights of Prescribing Information; , 2008. Cephalon Inc., Frazer, PA 19355.
[48]
Hartley, J.A. Alkylating agents. Oxford textbook of oncology.Ed. Oxford University Press, 2001, pp. 639-654.
[49]
Lorenzo, M. Leoni. Bendamustine: Rescue of an effective antineoplastic agent from the mid-twentieth century. Semin. Hematol., 2011, 48(1), S4-S11.
[50]
Cheson, B.D.; Leoni, L. Bendamustine: Mechanism of action and clinical data. Clin. Adv. Hematol. Oncol., 2011, 9(8), 19.
[51]
Arnau, M.; Eriong, L.; Jocabed, R.; Jiménez, L.; Cabezas, S.; Clot, G.; Pinyol, M.; Torrent, X.V.; Rosich, L.; Nardi, C.; Aymerich, M.; Villamor, N.; Guillermo, A.; Galan, P.; Roue, G.; Anglada, M.P.; Campo, E.; Guerra, L.; Colomer, D. CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia. Oncotarget, 2016, 7(5), 5507-5520.
[52]
Kalaycio, M. Clinical experience with Bendamustine: A new treatment for patients with chronic lymphocytic leukemia. Clin. Leuk., 2008, 2, 223-229.
[53]
Accessdata, FDA, VALCHLOR, Mechlorethamine gel, for topical use, Highlights of prescribing information,; , 2013. Reference ID 3362301, Ceptaris Therapeutics, Inc., Malvern, PA 19355.
[54]
Koler, R.D.; Forsgren, A.L. Hepatotoxicity due to Chlorambucil; report of a case. J. Am. Med. Assoc., 1958, 167(3), 316-317.
[55]
Fraiser, L.H.; Kanekal, S.; Kehrer, J.P. Cyclophosphamide toxicity. Characterizing and avoiding the problem. Drugs, 1991, 42(5), 781-795.
[56]
Accessdata, FDA, ALKERAN, Melphalan hydrochloride for injection, Prescribing Information,; , 2002. GlaxoSmithKline, Research Triangle Park, NC 27709..
[57]
Latcha, S.; Maki, R.G.; Schwartz, G.K.; Flombaum, C.D. Ifosfamide may be safely used in patients with end stage renal disease on hemodialysis. Sarcoma, 2009.Article ID 575629
[58]
Klastersky, J. Side effects of ifosfamide. Oncology, 2003, 65(2), 7-10.
[59]
Frisk, P.; Stalberg, E.; Stromberg, B.; Jakobson, A. Painful peripheral neuropathy after treatment with high-dose ifosfamide. Med. Pediatr. Oncol., 2001, 37(4), 379-382.
[60]
Knauf, W.U.; Lissichkov, T.; Aldaoud, A.; Liberati, A.; Loscertales, J.; Herbrecht, R.; Juliusson, G.; Postner, G.; Gercheva, L.; Goranov, S.; Becker, M.; Fricke, H.J.; Huguet, F.; Del, G.I.; Klein, P.; Tremmel, L.; Merkle, K.; Montillo, M. Phase III randomized study of Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J. Clin. Oncol., 2009, 27(26), 4378-4384.
[61]
Kahl, B.S.; Bartlett, N.L.; Leonard, J.P.; Chen, L.; Ganjoo, K.; Williams, M.E.; Czuczman, M.S.; Robinson, K.S.; Joyce, R.; Vander, J.R.H.; Cheson, B.D. Bendamustine is effective therapy in patients with Rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: Results from a Multicenter Study. Cancer, 2010, 116(1), 106-114.
[62]
Cheson, B.D.; Friedberg, J.W.; Kahl, B.S.; Vander, J.R.H.; Tremmel, L. Bendamustine produces durable responses with an acceptable safety profile in patients with Rituximab-refractory indolent non-Hodgkin lymphoma. Clin. Lymphoma Myeloma Leuk., 2010, 10(6), 452-457.
[63]
Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pfluger, K.H.; Schott, S.; Goede, V.; Isfort, S.; Von, T.J.; Fink, A.M.; Buhler, A.; Winkler, D.; Kreuzer, K.A.; Staib, P.; Ritgen, M.; Kneba, M.; Dohner, H.; Eichhorst, B.F.; Hallek, M.; Stilgenbauer, S.; Wendtner, C.M. Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: A multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol., 2012, 30(26), 3209-3216.
[64]
Ohmachi, K.; Niitsu, N.; Uchida, T.; Kim, S.J.; Ando, K.; Takahashi, N.; Takahashi, N.; Uike, N.; Eom, H.S.; Chae, Y.S.; Terauchi, T.; Tateishi, U.; Tatsumi, M.; Kim, W.S.; Tobinai, K.; Suh, C.; Ogura, M. Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. J. Clin. Oncol., 2013, 31(17), 2103-2109.
[65]
Borchers, A.T.; Hagie, F.; Keen, C.L.; Gershwin, M.E. The history and contemporary challenges of the US Food and Drug Administration. Clin. Ther., 2007, 29(1), 1-16.
[66]
Stephen, B. Over-the-counter products in line for user fee program. Pharm. Therapeut., 2017, 42(12), 723-724.
[67]
Kaitin, K.; Melville, A.; Morris, B. FDA advisory committees and the new drug approval process. J. Clin. Pharmacol., 1989, 29(10), 886-890.
[68]
Cristancho, R.A.; Andia, T.; Barbosa, T.; Watanabe, J.H. Definition and classification of generic drugs across the world. Appl. Health Econ. Health Policy, 2015, 13(1), 5-11.
[69]
Thakkar, K.B.; Billa, G. The concept of Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs. Front. Pharmacol., 2013, 4, 113.
[70]
Colombo, G.; Rosei, E.A.; Margonato, A.; Mencacci, A.; Maurizio, C.; Montecucco, C.M.; Trevisan, R. Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: A retrospective claims data study from five local healthcare units in the lombardy region of Italy. PLoS One, 2013, 8(12), 82990.
[71]
Garattini, L.; Vooren, K. Safety and quality of generic drugs: A never-ending debate fostered by economic interests? Appl. Health Econ. Health Policy, 2015, 13, 13-14.
[72]
Dunne, S.; Shannon, B.; Dunne, C.; Cullen, W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol. Toxicol., 2013, 14, 1.
[73]
Hansen, R.A.; Qian, J.; Berg, R.; Linneman, J.; Vazquez, E.S.; Dutcher, S.K.; Raofi, S.; David, C.; Peissig, P. Comparison of generic-to-brand switchback patterns for generic and authorized generic drugs. Pharmacotherapy, 2017, 37(4), 429-437.
[74]
Barlas, S. Brand and generics companies unite to pressure FDA: They want the agency to drop its safety-label plan and adopt their alternative. PT, 2015, 40(8), 501-503.
[75]
Handoo, S.; Arora, V.; Khera, D.; Nandi, P.K.; Sahu, S.K. A comprehensive study on regulatory requirements for development and filing of generic drugs globally. Int. J. Pharm. Investig., 2012, 2(3), 99-105.
[76]
Lionberger, A.; Lee, S.L.; Lee, L.M.; Raw, A.; Lawrence, X.Y. Quality by Design: Concepts for ANDAs. AAPS J., 2008, 10(2), 268-276.
[77]
Bedson, J.; Whitehurst, T.; Lewis, M.; Croft, P. Factors affecting over-the-counter use of aspirin in the secondary prophylaxis of cardiovascular disease. Br. J. Gen. Pract., 2001, 51(473), 1001-1003.
[78]
USFDA. Home, Drugs Development & Approval Process (Drugs), How Drugs are Developed and Approved, Types of Applications, DrugApplications for Over-the-Counter Drugs. fda.gov/drugs/ developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/over-the-counterdrugs/default.htm (Accessed Sept 05, 2018)
[79]
USFDA. Drugs Resources for You, Information for Consumers (Drugs), Buying & Using Medicine Safely, Generic Drugs. fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/GenericDrugs/default.html (Accessed Sept 05, 2018).
[80]
Drugs@FDA: FDA Approved Drug Products, MUSTARGEN,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006695 (Accessed Sept 05, 2018)
[81]
Drugs@FDA: FDA Approved Drug Products, VALCHLOR,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process (Accessed Sept 05, 2018
[82]
Drugs@FDA: FDA Approved Drug Products, LEUKERAN,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010669 (Accessed Sept 05, 2018)
[83]
Drugs@FDA: FDA Approved Drug Products, CYTOXAN,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012141 (Accessed Sept 05, 2018).
[84]
Drugs@FDA: FDA Approved Drug Products, ALKERAN,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=014691 (Accessed Sept 05, 2018)
[85]
Drugs@FDA: FDA Approved Drug Products, IFECX,. accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019763 (Accessed Sept 05, 2018)

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version500msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[21:24:34] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[21:24:34] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[21:24:34] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (107ms)time
  • Application (394ms)time
  • 1 x Application (78.66%)
    394ms
    1 x Booting (21.34%)
    107ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    37 statements were executed, 4 of which were duplicates, 33 unique. Show only duplicated320ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('314349518','',1,1740345874,1740345874) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740345874
      1.07msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('314349518','/article/97066',1,1740345874,1740345874)
      210μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 314349518 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 314349518) limit 1
      12.43msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 314349518
      • 1: 314349518
      • 2: 314349518
      • 3: 314349518
      • 4: 314349518
      • 5: 314349518
      • 6: 314349518
      • 7: 314349518
      • 8: 314349518
      • 9: 314349518
      • 10: 314349518
      • 11: 314349518
      • 12: 314349518
      • 13: 314349518
      • 14: 314349518
      • 15: 314349518
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=97066
      750μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 1 limit 1
      840μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 1
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid`) as `aggregate_table`
      1.19msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and sj.journal_id!=1 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      4.62msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=1) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      3.71msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '97066'
      1.33msalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 97066
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '97066'
      2.71msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 97066
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '97066' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      3.1msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 97066
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      270μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      630μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 1 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      48.77msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      17.62msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 1 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      16.84msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 97066 limit 1
      350μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 97066
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 97066 and content_type = 'article' order by status desc limit 1
      360μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid article_nid,a.title article_title,j.title journal_title from content_by_diseases cd inner join article a on a.article_id=cd.content_id inner join journal j on j.journal_id=a.journal_id where cd.pid = 16 and cd.sub_disease_id = 298 and content_id!=97066 and cd.content_type = 'article' order by rand() limit 20
      182msalphaeurekaselec_live_10_06_2022Article.php#769
      Backtrace
      • 11. app/Models/Article.php:769
      • 12. app/Http/Controllers/ArticleController.php:2098
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 170446 limit 1
      310μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 170446
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      290μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'ACAMC' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      380μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: ACAMC
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '97066' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      520μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '9284' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      440μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '2529' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      390μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2529) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2529) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 2529)
      9.74msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9284) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9284) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 9284)
      600μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 97066) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 97066) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 314349518 and j.to_ip >=314349518 )) and ((j.from_date <= 1740345874 and j.to_date >= 1740345874 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 97066)
      540μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '1080' and is_uploaded = 1 and issue_id = 9284 order by cast(first_page as SIGNED) desc limit 1
      450μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 1080
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '1102' and is_uploaded = 1 and issue_id = 9284 order by cast(first_page as SIGNED) asc limit 1
      400μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 1102
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      200μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      220μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 97066 limit 1
      3.58msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 97066
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740345874 and `b`.`banner_to_date` >= 1740345874 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.64msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740345874
      • 4: 1740345874
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 1 and `b`.`banner_from_date` <= 1740345874 and `b`.`banner_to_date` >= 1740345874 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.15msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 1
      • 3: 1740345874
      • 4: 1740345874
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='29f1a926d8a3dbf8545cc240f245fca0'
      210μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        zF7mragQm1qI1MQ5EnlGzKqYuzyQ3m9OzuEb49sO
        uc_cart_id
        29f1a926d8a3dbf8545cc240f245fca0
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/97066" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/97066
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6ImRLaUFEWkZNNkNvSG42Z1ZoZW9rV1E9PSIsInZhbHVlIjoidm8xTm5qdUQvenZBeEdyTkNlTHFTTStENlZheEtGSFkrUmRlZEJYNGRTQT0iLCJtYWMiOiJjNmYwOWU2NWI0NmEwNGUzMjk2NzRjMWYyMDJmMzU5ZTFlNWRlYTVlMWRiYmE0YWUwOTcyZTdiMTIxMzczMzgxIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6ImRLaUFEWkZNNkNvSG42Z1ZoZW9rV1E9PSIsInZhbHVlIjoidm8xTm5qdUQvenZBeEdyTkNlTHFTTStENlZheEtGSFkrUmRlZEJYNGRTQT0iLCJtYWMiOiJjNmYwOWU2NWI0NmEw" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Sun, 23 Feb 2025 21:24:34 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjE0UFZEZDNZQjNOdzFBNTU1RGV0SFE9PSIsInZhbHVlIjoiQXB1R1ZtT2Q5NURoWDVSdm9uRmxZNW8ycVloL0ZBbmdzMFMzKzVIMmRuTk5QeUNlSVVlUGVhNzRBSDVOeGxvTGt1NWNXR2Exb1hJYUZ2THJydytLVG1zTXhiWWY1RXI3K0l4YzN6UXIwNjlteDk1ZVd6ZlkvM3NzWk81T0xmcVMiLCJtYWMiOiI2MzNmMzQ4YzYxM2RjYTIyNmY0YTQzYWY2Mzg3YTQxYjgzZDFjZTE3YWI2MTQ1Njg0ZDg5ZTdjZjQwYjljNjYzIiwidGFnIjoiIn0%3D; expires=Wed, 26 Feb 2025 09:24:34 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6IjE0UFZEZDNZQjNOdzFBNTU1RGV0SFE9PSIsInZhbHVlIjoiQXB1R1ZtT2Q5NURoWDVSdm9uRmxZNW8ycVloL0ZBbmdzMFMzKzVIMmRuTk5QeUNlSVVlUGVhNzRBSDVOeGxvTGt1NWNXR" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImpMMkxnWittZGIreTIrYXBTa29PY0E9PSIsInZhbHVlIjoiMExmSU5HcHBGQ1VwZkEyNnNtcENmeHR0d1M4M29JUmlNREVvb3FKbHR6ZmsvWGFiVXB3a2FXeENHMGVRVVI3dkVEd1ZjZ2F4cGJXOWpTQkhmMC9ZM3N6eXdqUlpzK1M4NjQyeUhGVnRSQ05sMXB2VHhpamY4NnZLV2poVmVrS1YiLCJtYWMiOiI2MTgxYjVlMDZhNTk5NDcxYWJjZGVjMjcxYWIzNzM0NzUyZDg5MzU5ZjFiOGEwZjZkNDc4YTVlM2RiY2ZjOWI4IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6ImpMMkxnWittZGIreTIrYXBTa29PY0E9PSIsInZhbHVlIjoiMExmSU5HcHBGQ1VwZkEyNnNtcENmeHR0d1M4M29JUmlNREVvb3FKbHR6ZmsvWGFiVXB3a2FXeEN" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjE0UFZEZDNZQjNOdzFBNTU1RGV0SFE9PSIsInZhbHVlIjoiQXB1R1ZtT2Q5NURoWDVSdm9uRmxZNW8ycVloL0ZBbmdzMFMzKzVIMmRuTk5QeUNlSVVlUGVhNzRBSDVOeGxvTGt1NWNXR2Exb1hJYUZ2THJydytLVG1zTXhiWWY1RXI3K0l4YzN6UXIwNjlteDk1ZVd6ZlkvM3NzWk81T0xmcVMiLCJtYWMiOiI2MzNmMzQ4YzYxM2RjYTIyNmY0YTQzYWY2Mzg3YTQxYjgzZDFjZTE3YWI2MTQ1Njg0ZDg5ZTdjZjQwYjljNjYzIiwidGFnIjoiIn0%3D; expires=Wed, 26-Feb-2025 09:24:34 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6IjE0UFZEZDNZQjNOdzFBNTU1RGV0SFE9PSIsInZhbHVlIjoiQXB1R1ZtT2Q5NURoWDVSdm9uRmxZNW8ycVloL0ZBbmdzMFMzKzVIMmRuTk5QeUNlSVVlUGVhNzRBSDVOeGxvTGt1NWNXR" 1 => "alphaeurekaselectnet_session=eyJpdiI6ImpMMkxnWittZGIreTIrYXBTa29PY0E9PSIsInZhbHVlIjoiMExmSU5HcHBGQ1VwZkEyNnNtcENmeHR0d1M4M29JUmlNREVvb3FKbHR6ZmsvWGFiVXB3a2FXeENHMGVRVVI3dkVEd1ZjZ2F4cGJXOWpTQkhmMC9ZM3N6eXdqUlpzK1M4NjQyeUhGVnRSQ05sMXB2VHhpamY4NnZLV2poVmVrS1YiLCJtYWMiOiI2MTgxYjVlMDZhNTk5NDcxYWJjZGVjMjcxYWIzNzM0NzUyZDg5MzU5ZjFiOGEwZjZkNDc4YTVlM2RiY2ZjOWI4IiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6ImpMMkxnWittZGIreTIrYXBTa29PY0E9PSIsInZhbHVlIjoiMExmSU5HcHBGQ1VwZkEyNnNtcENmeHR0d1M4M29JUmlNREVvb3FKbHR6ZmsvWGFiVXB3a2FXeEN" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "zF7mragQm1qI1MQ5EnlGzKqYuzyQ3m9OzuEb49sO" "uc_cart_id" => "29f1a926d8a3dbf8545cc240f245fca0" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/97066" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-23 21:24:34GET/article/97066314371